Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2016

01-01-2016 | 2015 SSAT Plenary Presentation

Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy

Authors: Ryan W. Day, Brian D. Badgwell, Keith F. Fournier, Paul F. Mansfield, Thomas A. Aloia

Published in: Journal of Gastrointestinal Surgery | Issue 1/2016

Login to get access

Abstract

Background

Gastric cardia cancer is currently treated with several operations. The purpose of the current study was to compare outcomes associated with three common operative approaches.

Methods

The ACS-NSQIP Participant Use File was searched to identify all patients with gastric cardia malignancy who underwent total gastrectomy (TG), transhiatal esophagectomy (THE), or thoraco-abdominal esophagectomy (TAE) between 2005 and 2012. Demographic, perioperative risk factors, and outcomes were analyzed.

Results

Overall, there were 982 patients identified in the database who met inclusion criteria. The median age was 65 years (range 20–88) and 807 (82.2 %) were male. The number of patients allocated to each approach was 204 TGs (20.8 %), 271 THE (27.6 %), and 507 TAE (51.6 %). All approaches had similar major morbidity, cardiopulmonary morbidity, and 30-day mortality, however, TAE was associated with the highest overall morbidity (TAE 49.9 % vs. TG 40.7 % and THE 43.5 %, p = 0.048). The independent risk factors predicting mortality were age greater than 65 years, history of myocardial infarction, and postoperative cardiopulmonary morbidity.

Conclusions

For patients with proximal gastric cancer, the three most common operative approaches were associated with clinically-significant rates of overall and major morbidity. Approach-associated morbidity should be considered along with tumor location and extent when choosing a technique for resection of gastric cardia malignancy.
Literature
1.
go back to reference Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg. 1989;76(2):136–139.PubMedCrossRef Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg. 1989;76(2):136–139.PubMedCrossRef
2.
go back to reference Edge S BD, Compton Cc, Fritz Ag, Green Fl, Trotti A. AJCC Cancer Staging Manual. 2010. Edge S BD, Compton Cc, Fritz Ag, Green Fl, Trotti A. AJCC Cancer Staging Manual. 2010.
3.
go back to reference Rice TW, Blackstone EH and Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–1724.PubMedCrossRef Rice TW, Blackstone EH and Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–1724.PubMedCrossRef
4.
go back to reference Siewert JR, Holscher AH, Becker K and Gossner W. [Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg. 1987;58(1):25–32.PubMed Siewert JR, Holscher AH, Becker K and Gossner W. [Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg. 1987;58(1):25–32.PubMed
5.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef
6.
go back to reference Blot WJ, Devesa SS, Kneller RW and Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265(10):1287–1289.PubMedCrossRef Blot WJ, Devesa SS, Kneller RW and Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265(10):1287–1289.PubMedCrossRef
7.
go back to reference Devesa SS, Blot WJ and Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049–2053.PubMedCrossRef Devesa SS, Blot WJ and Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049–2053.PubMedCrossRef
8.
go back to reference Vial M, Grande L and Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1–17.PubMedCrossRef Vial M, Grande L and Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1–17.PubMedCrossRef
9.
go back to reference Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U and Wilkinson NW. Morbidity and Mortality Associated with Gastrectomy for Gastric Cancer. Ann Surg Oncol. 2014. Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U and Wilkinson NW. Morbidity and Mortality Associated with Gastrectomy for Gastric Cancer. Ann Surg Oncol. 2014.
10.
go back to reference Martin JT, Mahan A, Zwischenberger JB, Mcgrath PC and Tzeng CW. Should Gastric Cardia Cancers Be Treated with Esophagectomy or Total Gastrectomy? A Comprehensive Analysis of 4,996 NSQIP/SEER Patients. J Am Coll Surg. 2015;220(4):510–520.PubMedCrossRef Martin JT, Mahan A, Zwischenberger JB, Mcgrath PC and Tzeng CW. Should Gastric Cardia Cancers Be Treated with Esophagectomy or Total Gastrectomy? A Comprehensive Analysis of 4,996 NSQIP/SEER Patients. J Am Coll Surg. 2015;220(4):510–520.PubMedCrossRef
11.
go back to reference Yang K, Chen HN, Chen XZ, Lu QC, Pan L, Liu J, Dai B, Zhang B, Chen ZX, Chen JP and Hu JK. Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One. 2012;7(6):e37698.PubMedPubMedCentralCrossRef Yang K, Chen HN, Chen XZ, Lu QC, Pan L, Liu J, Dai B, Zhang B, Chen ZX, Chen JP and Hu JK. Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One. 2012;7(6):e37698.PubMedPubMedCentralCrossRef
12.
go back to reference Ahmed S, Iqbal N, Yadav S, Zaidi A, Ahmed O, Alvi R, Gardner D and Haider K. Time to adjuvant therapy and other variables in localized gastric and gastroesophageal junction (GEJ) cancer (IJGC-D-13-00162). J Gastrointest Cancer. 2014;45(3):284–290.PubMedCrossRef Ahmed S, Iqbal N, Yadav S, Zaidi A, Ahmed O, Alvi R, Gardner D and Haider K. Time to adjuvant therapy and other variables in localized gastric and gastroesophageal junction (GEJ) cancer (IJGC-D-13-00162). J Gastrointest Cancer. 2014;45(3):284–290.PubMedCrossRef
13.
go back to reference Lerut T, Moons J, Coosemans W, Van Raemdonck D, De Leyn P, Decaluwe H, Decker G and Nafteux P. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250(5):798–807.PubMedCrossRef Lerut T, Moons J, Coosemans W, Van Raemdonck D, De Leyn P, Decaluwe H, Decker G and Nafteux P. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250(5):798–807.PubMedCrossRef
14.
go back to reference Xia BT, Rosato EL, Chojnacki KA, Crawford AG, Weksler B and Berger AC. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction. World J Surg. 2013;37(2):408–415.PubMedCrossRef Xia BT, Rosato EL, Chojnacki KA, Crawford AG, Weksler B and Berger AC. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction. World J Surg. 2013;37(2):408–415.PubMedCrossRef
15.
go back to reference Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S and Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107–114.PubMedCrossRef Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S and Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107–114.PubMedCrossRef
16.
go back to reference Acs. User Guide for the 2012 ACS NSQIP. 2012. Acs. User Guide for the 2012 ACS NSQIP. 2012.
17.
go back to reference Tzeng CW, Cooper AB, Vauthey JN, Curley SA and Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014;16(5):459–468.PubMedCentralCrossRef Tzeng CW, Cooper AB, Vauthey JN, Curley SA and Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014;16(5):459–468.PubMedCentralCrossRef
18.
go back to reference Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A and Ponzano C. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241(2):232–237.PubMedPubMedCentralCrossRef Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A and Ponzano C. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241(2):232–237.PubMedPubMedCentralCrossRef
19.
go back to reference Biere SS, Van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, De Lange ES, Bonjer HJ, Van Der Peet DL and Cuesta MA. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):1887–1892.PubMedCrossRef Biere SS, Van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, De Lange ES, Bonjer HJ, Van Der Peet DL and Cuesta MA. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):1887–1892.PubMedCrossRef
20.
go back to reference Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ and Whang EE. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199(6):880–886.PubMedCrossRef Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ and Whang EE. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199(6):880–886.PubMedCrossRef
21.
go back to reference Lerut T, Moons J, Coosemans W, Decaluwe H, Decker G, De Leyn P, Nafteux P and Van Raemdonck D. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am. 2008;17(3):485–502, vii-viii.PubMedCrossRef Lerut T, Moons J, Coosemans W, Decaluwe H, Decker G, De Leyn P, Nafteux P and Van Raemdonck D. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am. 2008;17(3):485–502, vii-viii.PubMedCrossRef
22.
go back to reference Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol. 2005;31(6):595–604.PubMedCrossRef Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol. 2005;31(6):595–604.PubMedCrossRef
23.
go back to reference Coupland VH, Lagergren J, Luchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N and Moller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut. 2013;62(7):961–966.PubMedCrossRef Coupland VH, Lagergren J, Luchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N and Moller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut. 2013;62(7):961–966.PubMedCrossRef
24.
go back to reference Anderson O, Ni Z, Moller H, Coupland VH, Davies EA, Allum WH and Hanna GB. Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer. 2011;47(16):2408–2414.PubMedCrossRef Anderson O, Ni Z, Moller H, Coupland VH, Davies EA, Allum WH and Hanna GB. Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer. 2011;47(16):2408–2414.PubMedCrossRef
Metadata
Title
Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy
Authors
Ryan W. Day
Brian D. Badgwell
Keith F. Fournier
Paul F. Mansfield
Thomas A. Aloia
Publication date
01-01-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 1/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2949-2

Other articles of this Issue 1/2016

Journal of Gastrointestinal Surgery 1/2016 Go to the issue